News search
About the CNIC 23 Oct 2024 The National Center for Cardiovascular Research (CNIC), and the Health Research Institute of Hospital 12 de Octubre (i+12), representing SERMAS, are actively participating in JACARDI through different pilot projects |
Research 30 Sep 2024 A study published in The Journal of the American College of Cardiology (JACC) demonstrates that the burden and progression of silent atherosclerosis in |
Research 19 Sep 2024 A study from CNIC reveals how risk factors and subclinical atherosclerosis affect heart microcirculation in asymptomatic middle-aged individuals. The research, published in JACC: Cardiovascular Imaging, highlights the importance of assessing the heart vessels' ability to regulate blood flow and predict future cardiovascular risk |
Research 29 Jul 2024 A study by the CNIC and Fundación SHE, supported by “la Caixa” Foundation, demonstrates that schools are a crucial environment for health promotion in children |
About the CNIC 15 May 2024 Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total |
About the CNIC 12 Apr 2024 |
About the CNIC 10 Apr 2024 Guiomar Mendieta has been awarded the 2023 William W. Parmley Young Author Achievement Award for a paper published in JACC that is considered to an outstanding contribution in the field of atherosclerosis |
About the CNIC 9 Feb 2024 The National Center for Cardiovascular Research Carlos III (CNIC) is excited to announce the upcoming edition of the CNIC Conferences |
Research 23 Jan 2024 The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis |
- 1 of 6
- next ›